Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dr. MartensDOCMF -2.06%53 Capex-to-Operating-Income is 0.08 as of Mar. 2026, which is 64% below its 10-year median of 0.22. GuruFocus rates DOCMF with a GF Score™ of 53/100 and a GF Value™ of $0.97 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 465 Manufacturing - Apparel & Accessories companies, Dr. Martens ranks better than 70.54% on this metric.
Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.
Dr. Martens (OTCPK:DOCMF) Capex-to-Operating-Income Explanation
Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.
Dr. Martens Capex-to-Operating-Income Related Terms
Dr. Martens Capex-to-Operating-Income Historical Data
* Premium members only.
The historical data trend for Dr. Martens's Capex-to-Operating-Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DOCMF vs NKE, DECK, ONON: Capex-to-Operating-Income Comparison
For the Footwear & Accessories subindustry, Dr. Martens's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr. Martens Capex-to-Operating-Income vs Manufacturing - Apparel & Accessories Industry
For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Dr. Martens's Capex-to-Operating-Income distribution charts can be found below:
* The bar in red indicates where Dr. Martens's Capex-to-Operating-Income falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Capex-to-Operating-Income of 0.08 mean?
Dr. Martens (DOCMF) has a Capex-to-Operating-Income of 0.08 as of Mar. 2026. Capex to Operating Income ratio measures a company's investments in physical assets to its operating income. View historical data on Dr. Martens and its competitors. This is 64% below median its historical median of 0.22. Over the past decade, Dr. Martens' Capex-to-Operating-Income has ranged from 0.09 to 0.42. According to the industry distribution chart, Dr. Martens ranks #137 out of 465 companies in the Manufacturing - Apparel & Accessories industry, placing it in the top 29.5%.
Is Dr. Martens' Capex-to-Operating-Income too high?
Dr. Martens' current Capex-to-Operating-Income of 0.08 is 64% below median its 10-year median of 0.22. Over the past 10 years, this metric has ranged from a low of 0.09 to a high of 0.42. The Manufacturing - Apparel & Accessories industry median Capex-to-Operating-Income is 0.46. Dr. Martens' value of 0.08 is 82.6% below this industry median. Based on the distribution chart, Dr. Martens ranks #137 out of 465 companies in the Manufacturing - Apparel & Accessories industry, which is above the industry midpoint. Overall, Dr. Martens has a GF Score™ of 53/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dr. Martens' Capex-to-Operating-Income compare to NKE and DECK?
According to the Manufacturing - Apparel & Accessories industry distribution chart, Dr. Martens ranks #137 out of 465 companies for Capex-to-Operating-Income. This puts Dr. Martens in the upper half of its industry. The industry median Capex-to-Operating-Income is 0.46. Dr. Martens' value of 0.08 is 82.6% below this benchmark. Historically, Dr. Martens' own Capex-to-Operating-Income has ranged from 0.09 to 0.42 over the past decade. While the company's 10-year median is 0.22 vs. the industry median of 0.46, Dr. Martens has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Capex-to-Operating-Income for a Manufacturing - Apparel & Accessories company?
The median Capex-to-Operating-Income among Manufacturing - Apparel & Accessories companies is 0.46, based on 465 companies in the industry. Companies in the top quartile (top 25%) have a Capex-to-Operating-Income significantly above this median, while those in the bottom quartile fall well below. However, Capex-to-Operating-Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr. Martens's current Capex-to-Operating-Income of 0.08 is 82.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Capex-to-Operating-Income mean?
A high Capex-to-Operating-Income can signal that a stock is expensive relative to its fundamentals. Capex to Operating Income ratio measures a company's investments in physical assets to its operating income. View historical data on Dr. Martens and its competitors. For the Manufacturing - Apparel & Accessories industry, the median Capex-to-Operating-Income is 0.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr. Martens's current Capex-to-Operating-Income is 0.08, which is 64% below median its own 10-year median of 0.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr. Martens stock overvalued right now?
Based on GuruFocus' analysis, Dr. Martens (DOCMF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.97, compared to a current price of $1.09 — trading 11.9% above its estimated fair value. The current Capex-to-Operating-Income is 0.08, which is 64% below median its 10-year median of 0.22 and 82.6% below the Manufacturing - Apparel & Accessories industry median of 0.46. Dr. Martens' overall GF Score™ is 53/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Capex-to-Operating-Income calculated?
Capex-to-Operating-Income is calculated from a company's financial statements. For Dr. Martens (DOCMF), the current Capex-to-Operating-Income is 0.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr. Martens (DOCMF) Overvalued in 2026?
Based on GuruFocus' analysis, Dr. Martens stock appears to be overvalued.
The current stock price of $1.09 is trading 11.9% above its estimated GF Value™ of $0.97.
GuruFocus considers Dr. Martens to be Modestly Overvalued.
Key valuation signals for DOCMF:
Capex-to-Operating-Income: 0.08 (64% below median its 10-year median of 0.22)
GF Value™: $0.97 vs. price of $1.09 (11.9% above fair value)
Industry Position: 82.6% below the Manufacturing - Apparel & Accessories median (#137 of 465)
No single metric tells the full story. See the DOCMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr. Martens PLC is engaged in the footwear business. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. The company has sales through E-commerce, Retail, and Wholesale of Products. Geographically, it derives the majority of its revenue from EMEA and has a presence in the Americas and APAC.
53GF Score
Get the complete analysis for DOCMF
Capex-to-Operating-Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DOCMF has been successfully added to your 
